What is GPx?
GPx is dedicated to enhancing the lives of individuals managing chronic diseases through personalized and predictive innovations. The company's solutions are designed for ease of patient adoption and to empower clinicians in delivering superior care. By focusing on user-friendly technology and data-driven insights, GPx aims to redefine chronic disease management.
How much funding has GPx raised?
GPx has raised a total of $3.3M across 1 funding round:
Angel/Seed
$3.3M
Angel/Seed (2022): $3.3M with participation from Pete Moran, Hiroaki Kitano, and The D4V
Key Investors in GPx
Pete Moran
Contemporary Family Entertainment, associated with Pete Moran, focuses on creating engaging entertainment experiences for families, including themed spaces for leisure and relaxation.
The D4V
D4V (Design for Ventures) is a Japanese venture capital firm, a collaboration between IDEO and Genuine Startups, aimed at fostering Japanese startups for global success through design and capital.
What's next for GPx?
The recent enterprise-level funding positions GPx for accelerated growth and market expansion. This capital infusion is expected to fuel further development of its personalized health solutions, enhance its predictive analytics capabilities, and broaden its reach to more patients and healthcare providers. The company is poised to solidify its role as a leader in chronic disease management technology.
See full GPx company page
